Skip navigation
|
Contact Us
[
Viewing Options
]
Search this site
Home
Hepatitis C
The Liver & Hepatitis C
Living with Hepatitis C
Treatment
Wellness
Support
Hepatitis C Trust
News
News
News
2008
2007
2006
2005
2004
Print this page
Email to a friend
Comment on this page
Link to this page
Add page to favourites
News
>
News
News
Last updated:21January2008
Showing items 1 - 10 of 539
[
< Previous
]
[
Next >
]
European commission approves shorter 16 week treatment for certain geno 2 and 3 patients
Vertex announces new trial of telaprevir in non responders
Vertex CEO preparing for 09 hepatitis drug launch
Very Early Response to Interferon-based Therapy for Hepatitis C Is Apparent within the First 24 Hours
Course of Chronic Hepatitis C in Children
Central Asia: World Bank Warns Of Tainted Blood Transfusions Across Region
Poly-MVA - The First Dietary Supplement To Be Cleared By The FDA For Use In A Cancer Study
For Patients with HCV Genotype 6 - 48 Weeks Treatment is Superior to 24 Weeks
Active and Recovering Injection Drug Users Can Benefit from Hepatitis C Treatment if They Maintain Good Adherence
Will Vertex seek regulatory approval for telaprevir in 2009?
Showing items 1 - 10 of 539
[
< Previous
]
[
Next >
]
[
Sign In
]
[
Sign Up
]
